Swiss Re has announced the successful transfer of $275 million of extreme mortality risk to the capital markets through a securitisation programme with VITA Capital V Ltd.
The arrangement covers a five-year risk period starting in the issuance year and ending in 2017.
This latest Vita issuance extends the geographic coverage by including Australia for the first time.
“The continuing success of each Vita placement demonstrates its effectiveness in managing Swiss Re's capital and peak risk exposure, which further increases our ability to meet client needs,” said Matthias Weber, chief underwriting officer at Swiss Re.
To continue reading, you need a subscription to Intelligent Insurer. Start a subscription today for £655.
In-house feature articles, the archive and expert comment require a paid subscription. Subscribe now.
Want to give it a try? We are offering a two week free trial to the Intelligent Insurer website – register and select “Two Week Free Trial” to begin access to the full Intelligent Insurer archive and read the latest news, features and expert comment. Begin your free trial here.
Is your 2 week free trial about to end? Upgrade to a 12 month subscription for £655 now.
If you have already subscribed please login.
If you have any technical issues please contact support.
Swiss Re, extreme mortality protection, VITA Capital V Ltd